Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors

Podobne knjige/članki

• BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships
  od: Khorashad, Jamshid S., et al.
  Izdano: (2013)
• Mechanisms of Resistance to the BCR-ABL1 Allosteric Inhibitor Asciminib
  od: Qiang, Wang, et al.
  Izdano: (2017)
• Kinase Inhibitor Therapy in CML: It's What's Inside That Counts
  od: Eide, Christopher A., et al.
  Izdano: (2013)
• Radotinib is an Effective Inhibitor of Native and Kinase Domain-Mutant BCR-ABL1
  od: Zabriskie, Matthew S., et al.
  Izdano: (2015)
• Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
  od: Traer, Elie, et al.
  Izdano: (2011)